Catalysis Communications 79 (2016) 31–34
Contents lists available at ScienceDirect
Catalysis Communications
Short communication
Efficient enzymatic synthesis of ampicillin using mutant Penicillin G
acylase with bio-based solvent glycerol
c
Senwen Deng a,c,1, Xiaoqiang Ma c,1, Ming Sun c, , Dongzhi Wei , Erzheng Su
⁎
b,d,⁎⁎
a
School of Life Science, Hunan University of Science and Technology, Xiangtan 411201, Hunan, PR China
b
Enzyme and Fermentation Technology Laboratory, College of Light Industry Science and Engineering, Nanjing Forestry University, Nanjing 210037, PR China
State Key Laboratory of Bioreactor Engineering, New World Institute of Biotechnology, East China University of Science and Technology, Shanghai 200237, PR China
State Key Laboratory of Pulp and Paper Engineering, South China University of Technology, Guangzhou 510640, PR China
c
d
a r t i c l e i n f o
a b s t r a c t
Article history:
To fulfill the industry demand of ampicillin enzymatic synthesis, immobilized mutant Penicillin G acylase and
bio-based solvent glycerol were employed at high substrate concentration and low acyl donor/nucleophile
ratio. After process optimization, good yield and low operation costs were achieved.
© 2016 Elsevier B.V. All rights reserved.
Received 18 December 2015
Received in revised form 5 February 2016
Accepted 15 February 2016
Available online 17 February 2016
Keywords:
Penicillin G acylase
Antibiotic
Biocatalysis
Bio-based solvent
1. Introduction
Protein engineering is commonly used to tailor wild PGAs for SSBAs
synthesis [6,11–13]. For example, βF24G mutant of Penicillin G acylase
Semi-synthetic β-lactam antibiotics (SSBAs) are the most important
family of β-lactam antibiotics in the world market [1,2]. They were pro-
duced by the condensation of β-lactam moiety with the acyl side chain
[3]. Chemical synthesis of SSBAs has dominated the industrial produc-
tion of SSBAs for high yield (90%) [4]. But the complicated process
steps, harsh reaction conditions and large volume of organic solvent
needed, make them environmentally unsustainable [3,5]. Enzymatic
synthesis of SSBAs is an environmental friendly alternative, which is
mainly catalyzed by Penicillin G acylase (PGA: EC 3.5.1.11) [4], and
can be carried out under kinetically control (Fig. 1). But its relatively
low yield (40–60%), high process costs (raw material and catalyst),
complicated downstream processing (isolation and recycle) needed,
make it hard to fulfill the industry demand at present [3,5].
from Alcaligenes faecalis (Af PGA), in which the 24th Phenylalanine of
the β-subunit was replaced by Glycine was isolated for high S/H ratio
in this lab [13]. Also, this process can be improved by the addition of
water-miscible organic solvents, excess acyl donor and high substrate
concentration [6,14,15]. But these measures have to be taken carefully
in consideration of nucleophile conversion, raw material and down-
stream purification process costs. For example, the molar ratio acyl
donor/nucleophile should be as low as possible to reduce the costs of
raw materials and downstream processing. In the case of ampicillin,
amoxicillin and cephalexin, synthesis at high substrate concentration
has been proven to be beneficial [16–18]. However, this method could
be limited by substrate solubility, which could influence the conversion
of the nucleophile significantly. Medium engineering could improve
synthesis by increasing the S/H ratio. This has been proven for the
synthesis of cephaloglycine, ampicillin and cephalexin in methanol or
ethylene glycol [19–21]. But toxicity and biohazard of these solvents
have to be considered seriously. Ionic liquids were regarded as the sub-
stitution of organic solvents: e.g. Pereira et al. and Zhu et al. reported
enzymatic synthesis at the presence of ionic liquids [22,23]. But the
use of ionic liquids is still limited by high prices and lack of data about
the toxicity and bio-compatibility. As a bio-based solvent, glycerol
may combine the advantages of water and ionic liquids (low toxicity,
low price, large availability, renewability, high boiling point, low vapor
pressure), allows its use in the synthesis of pharmaceutically active in-
gredients [24,25].
Low yield of kinetically controlled synthesis can be mainly ascribed
to enzyme-catalyzed initial hydrolysis of the activated acyl donor and
the secondary hydrolysis of antibiotic product (Fig. 1) [6]. For natural
PGAs, low S/H (synthesis to hydrolysis) ratio is often observed [7–10].
⁎
Corresponding author.
⁎⁎ Correspondence to: E. Su, Enzyme and Fermentation Technology Laboratory, College
of Light Industry Science and Engineering, Nanjing Forestry University, Nanjing 210037,
PR China.
These authors contributed equally to this work.
1
1566-7367/© 2016 Elsevier B.V. All rights reserved.